Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney Disease Subjects on Hemodialysis
Sponsor
Abbott (Industry)
Overall Status
Completed
CT.gov ID
NCT00091481
Collaborator
(none)
201
19
10.6
Study Details
Study Description
Brief Summary
To show non-inferiority in the incidence rates of elevated calcium-phosphorus product between two treatment groups: 1) a group having an initial dose based on baseline PTH (baseline iPTH/80) and 2) a group having a starting dose based on body weight (0.04 mcg/kg).
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
Phase 4 |
Study Design
Study Type:
Interventional
Actual Enrollment
:
201 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double
Primary Purpose:
Treatment
Official Title:
A Randomized, Active-Controlled, Double-Blind Multi-Center Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney Disease Subjects on Hemodialysis
Study Start Date
:
Jun 1, 2003
Outcome Measures
Primary Outcome Measures
- Incidence rate of at least two consecutive calcium-phosphorus product levels greater than 65. []
Secondary Outcome Measures
- Evaluate the number of days to achieve the first of 2 consecutive > or = 30% decreases from baseline in PTH []
- The incidence rate for hypercalcemia []
- The incidence rate for hyperphosphatemia []
Eligibility Criteria
Criteria
Ages Eligible for Study:
20 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
Stage V Chronic Kidney Disease
-
Patients on Hemodialysis requiring treatment for secondary hyperparathyroidism with vitamin D therapy
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Errikos Dynan Hospital | Ambelokipi | Athens | Greece | 11526 |
2 | General Hospital of Athens, "G.Gennimatas" | Holargos | Athens | Greece | 11527 |
3 | General Hospital of Attica "Sismanoglio" | Marousi | Athens | Greece | 15126 |
4 | "Hygeia" Diagnosis and Therapy Center | Marousi | Athens | Greece | 152 00 |
5 | General Hospital of Melissia "Amalia Fleming" | Melissia | Athens | Greece | 15127 |
6 | General Hospital of Voula Askilpieion | Voula | Athens | Greece | 16673 |
7 | General Hospital of Heraklion | Voutes, Heraklion | Crete | Greece | |
8 | General Hospital Thessaloniki "Papanikolaou" | Exohi | Thessaloniki | Greece | 570 10 |
9 | General Hospital of Veria | Papagou Area | Veria | Greece | |
10 | Blue Cross Clinic | Athens | Greece | 11528 | |
11 | Evgenidio Clinic | Athens | Greece | 11528 | |
12 | Regional General Hospital of Athens "Korgialeneio-Benakeio" | Athens | Greece | ||
13 | General University Hospital of Alexandroupolis | Dragana | Greece | 68100 | |
14 | Regional General Hospital of Ioannina "Hatzikosta" | Ioannina | Greece | 450 01 | |
15 | General University Hospital Ioannina | Ioannina | Greece | 455 00 | |
16 | General Hospital of Nikea "Agios Panteleimon" | Nikea, Piraeus 18454, | Greece | ||
17 | General Hospital of Thessaloniki "Ahepa" | Thessaloniki | Greece | ||
18 | General Hospital of Thessaloniki "Hippokrateion" | Thessaloniki | Greece | ||
19 | General Hospital of Thessaloniki "Papageorgiou" | Thessaloniki | Greece |
Sponsors and Collaborators
- Abbott
Investigators
- Study Director: Jin Tian, M.D., Abbott
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00091481
Other Study ID Numbers:
- M01-367
First Posted:
Sep 13, 2004
Last Update Posted:
Sep 26, 2007
Last Verified:
Sep 1, 2007
Keywords provided by ,
,
Additional relevant MeSH terms: